Mumbai, April 4 -- The APA has also been inked with the subsidiaries of Manx, viz. Manx Pharma and Manx Generics.

Tillomed Laboratories is a leading European pharmaceutical company focused on developing, licensing, and marketing high-quality generic medicines. Headquartered in Luton, UK, Tillomed operates across multiple European markets, ensuring access to cost-effective healthcare solutions.

Under the APA, Tillomed will acquire Manx's product portfolio inclusive of relevant dossiers, marketing authorisations, intellectual property and the relevant stocks for around £19.7 million (including £4.7 million for inventory).

Of the total consideration, £6.2 million will be upfront and rest as milestone payments over the next ...